New study looks at how colorectal cancer cells ‘evade’ chemotherapy Jan 20, 2021 | Lunenfeld-Tanenbaum Research Institute A new study by a team of Toronto researchers looks at a mechanism that allows cancer cells to survive chemotherap...
Sinai Health receives $5 million for research into Hippo pathway Dec 10, 2020 | Lunenfeld-Tanenbaum Research Institute Sinai Health researchers are one step closer to identifying therapeutics that target a key mechanism in tumour gr...
Sinai Health study looks at whether health care workers are at higher risk of contracting SARS-CoV-2 Nov 26, 2020 | Lunenfeld-Tanenbaum Research Institute Canada’s COVID-19 Immunity Task Force (CITF) is supporting a Sinai Health study to find out how often and why hea...
New Sinai Health study looks at how cancer cells ‘feed’ Oct 15, 2020 | Lunenfeld-Tanenbaum Research Institute A new study by Sinai Health is shedding light on how cancer cells feed and grow, in findings that could one day l...
Coronavirus antibodies last at least three months after infection, study suggests Oct 8, 2020 | Lunenfeld-Tanenbaum Research Institute Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes ...
Bridging the transition from hospital to home Sep 29, 2020 | Hennick Bridgepoint Hospital, Lunenfeld-Tanenbaum Research Institute, Sinai Health Dr. Carolyn Steele Gray (left) and Dr. Michelle Nelson (centre) are a scientists at Bridgepoint’s Collaboratory f...